Evaluation of vascular calcification in relation to biomarker and vitminK in hemodialysis patients
Phase 3
- Conditions
- Chronic renal failure
- Registration Number
- JPRN-UMIN000011490
- Lead Sponsor
- Fujita Health University School of Medicine, Department of Nephrology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 207
Inclusion Criteria
Not provided
Exclusion Criteria
1. Remaining days are less than one year. 2. Women who are pregnant 3. Intake of vitamin K antagonists 4. Known hypersensitivity against vitamin k 5. History of thrombosis 6. Significant liver dysfunction 7. Inflammatory bowel disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Inhibition of vascular calcification. Comparison of the progression of the calcification index between vitamin K administration group and control group.
- Secondary Outcome Measures
Name Time Method 1. Comparison of vitamin K related biomarkers among between vitamin K administration group and control group. 2.Comparison of the change in DEXA between vitamin K administration group and control group.